Maira Biggiogero

Lugano, TI, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.

Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.

Journal: bioRxiv : the preprint server for biology

Published: January 30, 2023

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.

Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.

Journal: Science immunology

Published: January 26, 2023

Neutralization, effector function and immune imprinting of Omicron variants.

Neutralization, effector function and immune imprinting of Omicron variants.

Journal: Nature

Published: January 17, 2023

Long-Term Evolution of Activities of Daily Life (ADLs) in Critically Ill COVID-19 Patients, a Case Series.

Long-Term Evolution of Activities of Daily Life (ADLs) in Critically Ill COVID-19 Patients, a Case Series.

Journal: Healthcare (Basel, Switzerland)

Published: December 30, 2022

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.

Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.

Journal: bioRxiv : the preprint server for biology

Published: December 09, 2022

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.

Journal: bioRxiv : the preprint server for biology

Published: October 07, 2022

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.

Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape.

Journal: iScience

Published: September 27, 2022

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.

Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course.

Journal: Nature immunology

Published: July 11, 2022

Reply to Böning et al. Comment on "Ceruti et al. Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients. J. Clin. Med. 2022, 11, 788".

Reply to Böning et al. Comment on "Ceruti et al. Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients. J. Clin. Med. 2022, 11, 788".

Journal: Journal of clinical medicine

Published: June 23, 2022

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course.

Anti-chemokine antibodies after SARS-CoV-2 infection correlate with favorable disease course.

Journal: bioRxiv : the preprint server for biology

Published: June 06, 2022

A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study.

A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study.

Journal: Frontiers in oncology

Published: March 21, 2022

Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients.

Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients.

Journal: Journal of clinical medicine

Published: December 02, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026